SU; Xiping

Patent Applications and Registrations

Patent applications and USPTO patent grants for SU; Xiping.The latest application filed is for "substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl) amino compounds useful as jak 1 inhibitors".

Company Profile

0.3.9

SU; Xiping - Woodbridge CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl) Amino Compounds Useful As Jak 1 Inhibitors App 20220274992 - SU; Xiping ; et al.	2022-09-01
Synthetic Processes of Carprofen App 20170158637 - Yi; Lin ; et al.	2017-06-08
Synthetic processes of carprofen Grant 9,611,217 - Yi , et al. April 4, 2	2017-04-04
Synthetic Processes of Carprofen App 20160326113 - Yi; Lin ; et al.	2016-11-10
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders App 20140315910 - Caron; Judy ; et al.	2014-10-23
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders App 20130065904 - CARON; Judy ; et al.	2013-03-14
Process for preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1Napthalenamine Grant 8,329,950 - Caron , et al. December 11, 2	2012-12-11
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders App 20120123164 - CARON; Judy ; et al.	2012-05-17
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders App 20080293726 - Caron; Judy ; et al.	2008-11-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.